The UCSD CFAR has been in existence since 1994. It serves investigators at UCSD and three participating institutions: the Veterans Medical Research Foundation of the San Diego VA Healthcare System, the Salk Institute and the La Jolla Institute for Allergy and Immunology. The CFAR has significantly enhanced HIV/AIDS activities at the participating institutions and the San Diego Community in general by 1) encouraging young faculty and investigators new to mV/AIDS research through Developmental Grant Awards. 2) Providing expert advice and services in a number of specialized research areas through the CFAR Core Program and 3) fostering research interactions and community wide education through its programs in mentoring, training, education and outreach. The proposed CFAR consists of six cores: Developmental, Molecular Biology, Flow Cytometry (including the Immune Response sub-core), Genomics, Virology and Clinical Investigation. These cores are directly responsible to the Directors and the Executive Committee. Center membership is composed of the 180 faculty spanning 20 Departments in UCSD and the Center's participating institutions. The management of the Center is assisted by the Executive Committee, comprised of six investigators from UCSD and our collaborating institutions who are not directly funded by the CFAR: Bruce Torbett (The Scripps Research Institute), Ned Landau (Infectious Diseases, The Salk Institute), Carl Ware (The La Jolla Institute for Allergy and Immunology, LJIAI), Igor Grant (UCSD, HIV Neurobehavioral Research Center), Allen McCutchan (UCSD, NeuroAIDS), Sam Bozzette (UCSD, Health Services) and Josh Refer (Infectious Diseases, VA Medical Center, VAMC). In addition, our External Advisory Committee meets annually to monitor the scientific direction and growth of the CFAR as well as reviewing and evaluating individual core performance. The Committee offers feedback on our performance in achieving our milestones and aids in the formulation of new directions. The EAC is comprised of a group of internationally renowned AIDS investigators: Ron Desrosiers, David Ho, King Holmes, Eric Hunter, Gary Nabel and Mario Stevenson. Both committees provide us with the opportunity to draw upon and integrate their knowledge and advice, providing objective management decisions and helping guide the Center in new, productive directions. In the past year, several significant improvements have been incorporated into the program. These include a more formal and transparent administrative process of review and decision making, an enhanced Developmental Core, restructuring the CFAR membership into Program Areas to foster more collaboration and interaction and increased efforts in community education and outreach. These improvements are already enhancing the community wide HIV/AIDS activities by our already highly productive and useful CFAR.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-11
Application #
6754460
Study Section
Special Emphasis Panel (ZAI1-HSD-A (J1))
Program Officer
Young, Janet M
Project Start
1994-04-01
Project End
2007-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
11
Fiscal Year
2004
Total Cost
$1,568,793
Indirect Cost
Name
University of California San Diego
Department
Pathology
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Groessl, Erik J; Ganiats, Theodore G; Hillery, Naomi et al. (2018) Cost analysis of rapid diagnostics for drug-resistant tuberculosis. BMC Infect Dis 18:102
Dillon, Stephanie M; Guo, Kejun; Austin, Gregory L et al. (2018) A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis. AIDS 32:1599-1611
Goldenberg, Shira M; Rocha Jiménez, Teresita; Brouwer, Kimberly C et al. (2018) Influence of indoor work environments on health, safety, and human rights among migrant sex workers at the Guatemala-Mexico Border: a call for occupational health and safety interventions. BMC Int Health Hum Rights 18:9
Mehta, Sanjay R; Chaillon, Antoine; Gaines, Tommi L et al. (2018) Impact of Public Safety Policies on Human Immunodeficiency Virus Transmission Dynamics in Tijuana, Mexico. Clin Infect Dis 66:758-764
Dinesha, T R; Boobalan, J; Sivamalar, S et al. (2018) Occult HBV infection in HIV-infected adults and evaluation of pooled NAT for HBV. J Viral Hepat 25:718-723
Fraser, Hannah; Zibbell, Jon; Hoerger, Thomas et al. (2018) Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic. Addiction 113:173-182
Dinesha, Thongadi Ramesh; Boobalan, Jayaseelan; Sivamalar, Sathasivam et al. (2018) HIV, Hepatitis B Virus, and Hepatitis C Virus Prevalence Among High-Risk Populations in South India. AIDS Res Hum Retroviruses 34:327-328
Steinhardt, James J; Guenaga, Javier; Turner, Hannah L et al. (2018) Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity. Nat Commun 9:877
Thaney, Victoria E; Sanchez, Ana B; Fields, Jerel A et al. (2018) Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research. J Neurovirol 24:156-167
Stecher, Melanie; Hoenigl, Martin; Eis-Hübinger, Anna Maria et al. (2018) Hotspots of Transmission Driving the Local Hiv Epidemic in the Cologne-Bonn Region, Germany. Clin Infect Dis :

Showing the most recent 10 out of 921 publications